IL81162A - N-methyl-d-aspartate antagonistic pharmaceutical compositions containing bridged tricyclic imine derivatives - Google Patents

N-methyl-d-aspartate antagonistic pharmaceutical compositions containing bridged tricyclic imine derivatives

Info

Publication number
IL81162A
IL81162A IL81162A IL8116287A IL81162A IL 81162 A IL81162 A IL 81162A IL 81162 A IL81162 A IL 81162A IL 8116287 A IL8116287 A IL 8116287A IL 81162 A IL81162 A IL 81162A
Authority
IL
Israel
Prior art keywords
aspartate
methyl
pharmaceutical compositions
compositions containing
imine derivatives
Prior art date
Application number
IL81162A
Other languages
English (en)
Original Assignee
Merkc Sharp And Dohme Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merkc Sharp And Dohme Limited filed Critical Merkc Sharp And Dohme Limited
Publication of IL81162A publication Critical patent/IL81162A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL81162A 1986-01-14 1987-01-05 N-methyl-d-aspartate antagonistic pharmaceutical compositions containing bridged tricyclic imine derivatives IL81162A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868600783A GB8600783D0 (en) 1986-01-14 1986-01-14 N-methyl-d-aspartate receptor antagonists

Publications (1)

Publication Number Publication Date
IL81162A true IL81162A (en) 1990-12-23

Family

ID=10591339

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81162A IL81162A (en) 1986-01-14 1987-01-05 N-methyl-d-aspartate antagonistic pharmaceutical compositions containing bridged tricyclic imine derivatives

Country Status (8)

Country Link
US (1) US4888347A (da)
EP (1) EP0230370B1 (da)
JP (1) JP2549643B2 (da)
CA (1) CA1284952C (da)
DE (1) DE3780972T2 (da)
DK (1) DK170921B1 (da)
GB (1) GB8600783D0 (da)
IL (1) IL81162A (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806543A (en) * 1986-11-25 1989-02-21 Board Of Trustees Of The Leland Stanford Junior University Method and compositions for reducing neurotoxic injury
GB8719199D0 (en) * 1987-08-13 1987-09-23 Merck Sharp & Dohme Chemical compounds
GB8727989D0 (en) * 1987-11-30 1988-01-06 Merck Sharp & Dohme Therapeutic agents
DE3839659A1 (de) * 1988-11-24 1990-05-31 Boehringer Ingelheim Kg Verwendung von benzomorphanen zur zytoprotektion
US5399572A (en) * 1989-02-17 1995-03-21 Aktiebolaget Astra Chlormethiazole in the treatment of neurodegeneration
US5011834A (en) * 1989-04-14 1991-04-30 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon PCP receptor ligands and the use thereof
US5688789A (en) * 1989-04-14 1997-11-18 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon PCP receptor ligands and the use thereof
JP2899062B2 (ja) * 1989-09-28 1999-06-02 協和醗酵工業株式会社 化合物ｅｓ―２４２
EP0424179A3 (en) * 1989-10-20 1991-12-27 John William Olney Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration
US5474990A (en) * 1989-10-20 1995-12-12 Olney; John W. Barbiturates as safening agents in conjunction with NMDA antagonists
US5229394A (en) * 1990-07-30 1993-07-20 Arch Development Corporation Method for treatment of amyotrophic lateral sclerosis comprising administration of dmp
SE9002659D0 (sv) 1990-08-15 1990-08-15 Astra Ab New pharmaceutical formulations
US5064831A (en) * 1990-09-14 1991-11-12 Bristol-Myers Squibb Co. Naphthothiophenimines for treating neuronal disorders caused by ischemia
US5141934A (en) * 1990-10-30 1992-08-25 Warner-Lambert Company Tetracyclic amines having pharmaceutical activity
US5118675A (en) * 1991-02-15 1992-06-02 American Home Products Corporation Quinoxaline phosphono-amino acids
US5455279A (en) * 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine
AU2159792A (en) * 1991-06-05 1993-01-08 United States Of America, As Represented By The Secretary Of The Army, The A method of treating infectious encephalitis of viral or bacterial, or parasitic pathogenesis
US5206264A (en) * 1991-11-04 1993-04-27 Cypros Pharmaceutical Corporation Use of disulfiram to prevent cardiovascular damage
GB9206266D0 (en) * 1992-03-23 1992-05-06 Merck Sharp & Dohme Therapeutic agents
AU4540193A (en) * 1992-06-17 1994-01-04 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Method of treating and protecting against central nervous system ischemia, hypoxia, degeneration, and trauma with a 5-aminocarbonyl-sh-dibenzo{a,d}cyclohepten-5,10-imine
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5554620A (en) * 1993-09-14 1996-09-10 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
RU2106864C1 (ru) 1995-10-23 1998-03-20 Николай Серафимович Зефиров Средство для лечения болезни альцгеймера
US6025355A (en) * 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US20060142186A1 (en) * 2004-12-23 2006-06-29 Voyager Pharmaceutical Corporation Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer's disease
KR100888379B1 (ko) * 2007-05-31 2009-03-13 한국과학기술연구원 성상교세포-뉴런 간 신호 전달 기작
KR101707907B1 (ko) * 2013-09-09 2017-02-17 제일모직 주식회사 화합물, 이를 포함하는 유기 광전자 소자 및 표시장치
WO2017216159A1 (en) * 2016-06-13 2017-12-21 Institut National De La Santé Et De La Recherche Médicale (Inserm) Novel dizocilpine derivatives as peripheral nmda receptor antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064139A (en) * 1975-04-07 1977-12-20 Merck & Co., Inc. Substituted 9,10-dihydroanthracen-9,10-imines
US4374838A (en) * 1977-09-19 1983-02-22 Merck & Co., Inc. Dibenzo[a,d]cycloocten-5,12-(and 6,12)-imines
US4399141A (en) * 1977-09-19 1983-08-16 Merck & Co., Inc. 5-Alkyl or hydroxyalkyl substituted-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imines and anticonvulsant use thereof
NL7808848A (nl) 1977-09-19 1979-03-21 Merck & Co Inc Dibenzoa.dcyclo-octeen-5.12-(en 6.12)-iminen.
US4657899A (en) * 1986-04-09 1987-04-14 Nova Pharmaceutical Corporation Antagonists of specific excitatory amino acid neurotransmitter receptors

Also Published As

Publication number Publication date
US4888347A (en) 1989-12-19
CA1284952C (en) 1991-06-18
GB8600783D0 (en) 1986-02-19
EP0230370A3 (en) 1990-05-23
EP0230370B1 (en) 1992-08-12
DK170921B1 (da) 1996-03-18
EP0230370A2 (en) 1987-07-29
DK14587A (da) 1987-07-15
DE3780972T2 (de) 1993-03-04
DE3780972D1 (de) 1992-09-17
JPS62181216A (ja) 1987-08-08
DK14587D0 (da) 1987-01-13
JP2549643B2 (ja) 1996-10-30

Similar Documents

Publication Publication Date Title
IL81162A (en) N-methyl-d-aspartate antagonistic pharmaceutical compositions containing bridged tricyclic imine derivatives
IL96241A0 (en) Aromatic amine compounds,their preparation and pharmaceutical compositions containing them
IL84522A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL89205A (en) Chloroaniline derivatives, their preparation and pharmaceutical compositions containing them
IL82421A0 (en) Pharmaceutical compositions containing heterocyclic compounds,certain such novel compounds and their preparation
IL91361A0 (en) Tricyclic compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
IL68498A0 (en) Tricyclic compounds,their preparation and pharmaceutical compositions containing them
IL84612A (en) Heteroaromatic amine derivatives,their preparation and pharmaceutical compositions containing them
IL100061A0 (en) Tricyclic compounds,their preparation and pharmaceutical compositions containing them
IL83432A0 (en) Phenyl butenamide derivatives,their preparation and pharmaceutical compositions containing them
IL87794A0 (en) Tricyclic amidino derivatives,their preparation and pharmaceutical compositions containing them
IL98756A0 (en) Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation
NZ220650A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
IL93136A0 (en) Tetrahydroimidazo(1,4)benzodiazepin-2-thione derivatives,their preparation and pharmaceutical compositions containing them
NZ220176A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
IL98223A0 (en) Pharmaceutical compositions containing fluorene derivatives,some such novel compounds and their preparation
IL79222A0 (en) 2-oxy-4h-3,1-benzoxazin-4-one derivatives and related compounds,their preparation and pharmaceutical compositions containing them
IL98691A0 (en) Tricyclic compounds containing heteroatoms,their preparation and pharmaceutical compositions containing them
IL94763A0 (en) R(-)3-quinuclidinol derivatives,their preparation and pharmaceutical compositions containing them
IL84128A0 (en) 3-propenylcephem derivatives,their preparation and pharmaceutical compositions containing them
ZA871766B (en) Acetamide derivatives,their preparation and pharmaceutical compositions containing them
IL81410A (en) Pharmaceutical compositions containing substituted n-arylmethylamine derivatives,certain such novel compounds and their preparation
IL90389A0 (en) Tricyclic 3-oxo-propanenitrile derivatives,their preparation and pharmaceutical compositions containing them
IL84636A0 (en) Lactam derivatives,their preparation and pharmaceutical compositions containing them
NZ220926A (en) Tricyclic compounds and pharmaceutical compositions

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees